Nov 07, 2018 | Adam Bonislawski
In The News
GenomeWeb | November 08, 2018
GenomeWeb | November 07, 2018
NEW YORK (GenomeWeb) – Expedeon said today it has signed a supply and license agreement with Quanterix to provide that company non-exclusive access to its immunoassay offerings.
GenomeWeb | November 01, 2018
NEW YORK (GenomeWeb) – Quanterix reported after the close of the market on Thursday that its third quarter revenues rose 85 percent year-over-year, thanks largely to an 82 percent increase in quarterly product revenues.
Multiple Sclerosis News Today | October 12, 2018
By Jose Marques Lopez, PhD
Enjoyed discussing the future of cancer care and the role biomarkers will play in advancing less invasive detection options, more accurate diagnoses and more personalized treatment pathways with PharmaVOICE.
September 25, 2018
In a recent interview with Baystate Business, Kevin Hrusovsky, Quanterix Chairman and CEO and founder of Powering Precision Health, explains the fundamentals of Quanterix technology and how it's disrupting the way healthcare is practiced. Click the file below to hear the interview.
SPORTTECHIE | September 07, 2018
By Joe Lemire
Digital Biotech | September 07, 2018
Kevin Hrusovsky, Quanterix Chairman and CEO and Founder of Powering Precision Health, recently sat down with TetraScience CEO Alok Tayi to talk about the exciting work that Quanterix is doing in the area of clinical biomarkers and the business of diagnostics, as well as healthcare, more broadly,
SPORTTECHIE | September 06, 2018
By Joe Lemire